Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Noris

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Thrombosis and Haemostasis : JTH|September 11, 2009
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopeniaP Noris, C Klersy, M Zecca, et al.
Leukemia|December 26, 2001
Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantationC L Balduini, L Salvaneschi, C Klersy, et al.
Vox Sanguinis|December 16, 1998
Autologous platelet collection and storage to support thrombocytopenia in patients undergoing high-dose chemotherapy and circulating progenitor cell transplantation for high-risk breast cancerL Torretta, C Perotti, P Pedrazzoli, et al.
British Journal of Haematology|April 12, 2000
Transfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: a pilot studyP Pedrazzoli, P Noris, C Perotti, et al.
Journal of Thrombosis and Haemostasis : JTH|December 23, 2014
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopeniaP A Basciano, J Matakas, A Pecci, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2012
Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR studyW Ageno, N Riva, P Noris, et al.
Haematologica|October 30, 1998
Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancerP Pedrazzoli, C Perotti, P Noris, et al.
Blood|August 1, 1995
Max(a), a new low-frequency platelet-specific antigen localized on glycoprotein IIb, is associated with neonatal alloimmune thrombocytopeniaP Noris, S Simsek, L G de Bruijne-Admiraal, et al.
Journal of Thrombosis and Haemostasis : JTH|June 8, 2012
International collaboration as a tool for diagnosis of patients with inherited thrombocytopenia in the setting of a developing countryA C Glembotsky, R F Marta, A Pecci, et al.
Nature Genetics|September 6, 2000
Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome ConsortiumM Seri, R Cusano, S Gangarossa, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Thrombosis and Haemostasis : JTH|September 11, 2009
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopeniaP Noris, C Klersy, M Zecca, et al.
Leukemia|December 26, 2001
Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantationC L Balduini, L Salvaneschi, C Klersy, et al.
Vox Sanguinis|December 16, 1998
Autologous platelet collection and storage to support thrombocytopenia in patients undergoing high-dose chemotherapy and circulating progenitor cell transplantation for high-risk breast cancerL Torretta, C Perotti, P Pedrazzoli, et al.
British Journal of Haematology|April 12, 2000
Transfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: a pilot studyP Pedrazzoli, P Noris, C Perotti, et al.
Journal of Thrombosis and Haemostasis : JTH|December 23, 2014
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopeniaP A Basciano, J Matakas, A Pecci, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2012
Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR studyW Ageno, N Riva, P Noris, et al.
Haematologica|October 30, 1998
Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancerP Pedrazzoli, C Perotti, P Noris, et al.
Blood|August 1, 1995
Max(a), a new low-frequency platelet-specific antigen localized on glycoprotein IIb, is associated with neonatal alloimmune thrombocytopeniaP Noris, S Simsek, L G de Bruijne-Admiraal, et al.
Journal of Thrombosis and Haemostasis : JTH|June 8, 2012
International collaboration as a tool for diagnosis of patients with inherited thrombocytopenia in the setting of a developing countryA C Glembotsky, R F Marta, A Pecci, et al.
Nature Genetics|September 6, 2000
Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome ConsortiumM Seri, R Cusano, S Gangarossa, et al.
Pageof 5